The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimal preoperative multidisciplinary treatment in borderline resectable pancreatic cancer: Results of a dual-center study.
 
Nana Kimura
No Relationships to Disclose
 
Suguru Yamada
No Relationships to Disclose
 
Hideki Takami
No Relationships to Disclose
 
Kenta Murotani
No Relationships to Disclose
 
Isaku Yoshioka
No Relationships to Disclose
 
Kazuto Shibuya
No Relationships to Disclose
 
Fuminori Sonohara
No Relationships to Disclose
 
Yui Hoshino
No Relationships to Disclose
 
Katsuhisa Hirano
No Relationships to Disclose
 
Toru Watanabe
No Relationships to Disclose
 
Hayato Baba
No Relationships to Disclose
 
Kosuke Mori
No Relationships to Disclose
 
Takeshi Miwa
No Relationships to Disclose
 
Haruyoshi Tanaka
No Relationships to Disclose
 
Mitsuro Kanda
No Relationships to Disclose
 
Masamichi Hayashi
No Relationships to Disclose
 
Koshi Matsui
No Relationships to Disclose
 
Tomoyuki Okumura
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly; MSD K.K; Nippon Kayaku; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Research Funding - abbott Japan (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Maruho (Inst); MSD (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst)
 
Tsutomu Fujii
No Relationships to Disclose